OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)

OPTUS Pharmaceutical Revenue

OPTUS Pharmaceutical had revenue of 23.19B KRW in the quarter ending March 31, 2026, with 23.83% growth. This brings the company's revenue in the last twelve months to 91.62B, up 11.80% year-over-year. In the year 2025, OPTUS Pharmaceutical had annual revenue of 87.16B with 6.42% growth.

• Revenue (ttm): 91.62B
• Revenue Growth: +11.80%
• P/S Ratio: 1.12
• Revenue / Employee: 576.26M
• Employees: 159
• Market Cap: 102.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.16B	5.26B	6.42%
Dec 31, 2024	81.90B	9.48B	13.09%
Dec 31, 2023	72.43B	13.77B	23.47%
Dec 31, 2022	58.66B	1.34B	2.34%
Dec 31, 2021	57.32B	-3.51B	-5.77%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error